Ignite Creation Date:
2024-05-05 @ 6:38 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00510471
Status:
TERMINATED
Last Update Posted:
2008-03-18
First Post:
2007-07-31
Brief Title:
Personalized Active Immunotherapy Vaccine Therapy and Sargramostim Given After Standard of Care Treatment With Rituximab and Chemotherapy for Initial Treatment With Lymphoma
Sponsor:
Genitope Corporation
Organization:
Genitope Corporation
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-05
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2007-07-31
First Submit QC Date:
July 31 2007
Study First Post Date:
2007-08-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2008-03-14
Last Update Post Date:
2008-03-18
Last Update Post Date Type:
ESTIMATED